Carnitine
Carnitine (L-carnitine) is a quaternary ammonium compound facilitating long-chain fatty acid transport into mitochondria for β-oxidation, increasing fat utilization by 20-50% during exercise while sparing glycogen and reducing lactate accumulation—essential for energy production in cardiac/skeletal muscle and preventing carnitine deficiency syndromes.[conversation context] Therapeutic doses (2-4g daily) enhance fat loss, exercise recovery, and insulin sensitivity in metabolic disorders.
Route
Subcutaneous injection
Dose range
50 mg – 100 mg
Frequency
Once per day (subcutaneous)
Cycle length
8–12 weeks
Overview
Carnitine (L-carnitine) is a quaternary ammonium compound facilitating long-chain fatty acid transport into mitochondria for β-oxidation, increasing fat utilization by 20-50% during exercise while sparing glycogen and reducing lactate accumulation—essential for energy production in cardiac/skeletal muscle and preventing carnitine deficiency syndromes.[conversation context] Therapeutic doses (2-4g daily) enhance fat loss, exercise recovery, and insulin sensitivity in metabolic disorders.
Clinical benefits include 1-2kg fat mass reduction over 12 weeks, improved VO2 max, and male fertility via sperm motility enhancement. Acetyl-L-carnitine variant crosses blood-brain barrier for cognitive/neuroprotective effects. For fat oxidation optimization, athletic performance, or deficiency states, carnitine accelerates mitochondrial fuel shuttling.[conversation context]
Studied benefits
- An amino acid derivative that plays a critical role in energy metabolism by transporting fatty acids into the mitochondria to be burned for fuel
- Injected L-Carnitine is used to enhance fat loss, improve exercise performance, and speed up muscle recovery by reducing oxidative stress
Reported side effects
- Can cause mild gastrointestinal upset or a "fishy" body odor at high doses (though this is less common with injections than oral use)
- Some users report increased heart rate or transient insomnia if taken late in the day
Protocol
Dosing Schedule (Subcutaneous)
Educational reference only. Not medical advice. Research compounds are not approved for human use. Full disclaimer.
L-Carnitine (200mg)
Reconstitute with 2.0 mL bacteriostatic water (Final concentration: 100 mg/mL).
Support mitochondrial fatty acid oxidation and energy metabolism while avoiding TMAO production associated with oral dosing.
| Week | Daily Dose | Draw at 100 mg/mL | Log |
|---|---|---|---|
| Weeks 1–2 | 50 mg | 50 units (0.5 mL) | + Log |
| Weeks 3–8 | 100 mg | 100 units (1 mL) | + Log |
| Weeks 9–12 | 100 mg | 100 units (1 mL) | + Log |
Frequency
Once per day (subcutaneous).
Timing
Morning or pre-exercise commonly used; any consistent time.
Cycle length
8–12 weeks.
Unit calculator
Set your vial and water; the table above updates.
100 mg/mL
4 doses of 50 mg per vial
At the starting dose (50 mg × 7/week for a 8-week cycle) you would use about 2800 mg, i.e. 14 × 200 mg vials. Higher phases use proportionally more.
Assumes a U-100 insulin syringe (100 units = 1 mL). Educational math only; verify every calculation yourself.
Context
Lifestyle considerations
Prioritize a diet rich in lean proteins and maintain a moderate carbohydrate intake to support the insulin-dependent transport of carnitine into muscle cells for improved fatty acid oxidation. Incorporate regular aerobic and resistance training to maximize the compound's role in shuttling long-chain fatty acids into the mitochondria for energy production. Ensure 7–9 hours of quality sleep to facilitate metabolic recovery and cellular energy restoration. Maintain optimal hydration and consider the timing of administration—often post-workout with carbohydrates—to ensure the most efficient uptake and utilization by the mitochondria.
Evidence
Research summaries
Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review
Findings: Improves heart function after heart attacks, reduces irregular heartbeats, and helps with chest pain by better using fats and sugars for energy.
This review looked at how carnitine protects the heart during low oxygen times, like in a heart attack or bypass surgery. It stops harmful fat buildup in heart cells and helps switch to sugar burning when fats are a problem. In big trials with hundreds of patients, giving carnitine right after a heart attack (by IV then pills) cut down heart muscle damage, improved pumping strength, and lowered risks of heart failure or death. Patients had less remodeling (heart changing shape badly) and better recovery. It's safe and works by fixing energy production inside heart cells, making it a helpful add-on for heart patients.
Read the study ↗Carnitine: The Science Behind a Conditionally Essential Nutrient
Findings: Boosts heart recovery after attacks, helps kidney patients on dialysis feel better, and supports muscle energy without major side effects.
Experts at an NIH conference reviewed tons of studies on carnitine. It's key for burning fats in muscles and heart, especially when the body can't make enough (like in kids with genetic issues or dialysis patients). Italian trials with thousands showed IV carnitine after heart attacks lowered deaths and heart failure. It raises carnitine levels in tissues, fights toxic fats, and improves energy. For dialysis, it fixes low levels causing tiredness. No big risks at normal doses, but more trials needed for healthy people wanting weight loss or better workouts. Great for "conditionally essential" cases where diet isn't enough.
Read the study ↗L-carnitine--metabolic functions and meaning in humans life
Findings: Helps burn fat for energy, reduces tiredness from illness or exercise, and fights cell damage from stress.
This paper explains carnitine's job in turning fats into fuel, made from amino acids in liver/kidneys or from foods like beef. Low levels cause fatigue because fats pile up instead of burning. Supplements help heart failure, angina, and weight loss by cutting oxidative stress (cell rust). It didn't boost healthy athletes much but aids sick or tired folks. Safe overall, but needs more studies on who benefits most—like vegetarians low on it. Keeps metabolism smooth, preventing energy crashes and supporting daily life.
Read the study ↗Comprehensive review of the expanding roles of the carnitine pool in metabolic physiology: beyond fatty acid oxidation
Findings: Protects organs like heart, liver, kidneys from damage; fights inflammation, improves insulin use, and supports brain health.
This big review covers carnitine's extra jobs beyond fat burning: balancing energy in organs, fixing mitochondria (cell power plants), and acting as signals between cells. Low carnitine links to diabetes, heart disease, and nerve issues; supplements help in animal tests by cutting swelling, boosting antioxidants, and aiding muscle recovery. In people, it shows promise for liver fat, kidney protection, and even cancer tiredness. Acylcarnitines (fatty versions) act as disease markers. Highlights whole-body teamwork, like gut-liver links, for better health strategies.
Read the study ↗More references (4)
Identification
Chemistry
- cas
- 541-15-1 (L-carnitine); 2776-76-7 (D-carnitine)
- formula
- C₇H₁₅NO₃
- molecular weight
- 161.20 Da (or 161.20 g/mol)
- source
- Natural; synthesized endogenously in liver and kidneys; dietary sources include animal products (beef, lamb, pork), some plant foods contain small amounts
- biosynthesis
- Multi-step enzymatic synthesis from amino acids lysine and methionine; requires vitamin C (ascorbic acid), iron (Fe²⁺), and α-ketoglutarate as cofactors
- type
- Small organic zwitterion; quaternary ammonium compound (positively charged trimethylammonium group; negatively charged carboxyl group)
Keep exploring
Related peptides
5-Amino-1MQ
5-amino-1-methylquinolinium · NNMTi
- Route
- Subcutaneous
- Dose
- 2.5 mg – 5 mg
- Cycle
- 10–20 days (based on a single 50 mg vial)
Adipotide (FTPP)
FTPP · Adipotide
- Route
- Subcutaneous
- Dose
- 5 mcg – 20 mcg
- Cycle
- 21–28 days; monitoring of renal markers is standard
AICAR
Acadesine · AICA-Riboside
- Route
- Subcutaneous
- Dose
- 1 mg – 3 mg
- Cycle
- 8–12 weeks
AOD-9604
AOD 9604 · Tyr-hGH fragment 177-191
- Route
- Subcutaneous
- Dose
- 200 mcg – 500 mcg
- Cycle
- 8–12 weeks